Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy

Journal of the American College of Cardiology

Volumn 29, Issue 7, 1997, Pages 1422-1431

  Benowitz, Neal L ^a   Gourlay, Steven G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK MANAGEMENT; SMOKING CESSATION; THROMBOSIS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030955437     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00079-X     Document Type: Review

References (123)

1. McBride PE. The health consequences of smoking cardiovascular diseases . Med Clin North Am. 76:1992;333-353.
2. Wilhelmsen L. Coronary heart disease epidemiology of smoking and intervention studies of smoking . Am Heart J. 115:1988;242-249.
3. Lepantalo M, Lassila R. Smoking and occlusive peripheral arterial disease. Eur J Surg. 157:1991;83-87.
4. Nobuyoshi M, Masayuki A, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm identification of the most important determinant . Am Heart J. 124:1992;32-38.
5. Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management incidence and effect of smoking . J Am Coll Cardiol. 16:1990;340-348.
6. Maouad J, Fernandez F, Hebert JL, Zamani K, Barrillon A, Gay J. Cigarette smoking during coronary angiography diffuse or focal narrowing (spasm) of the coronary arteries in 13 patients with angina at rest and normal coronary angiograms . Cathet Cardiovasc Diagn. 12:1986;366-375.
7. Galan KM, Deligonul U, Kern MJ, Chaitman BR, Vandormael MG. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol. 61:1988;260-263.
8. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 91:1995;298-303.
9. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers epidemiologic findings . Am Heart J. 111:1986;932-940.
10. Pickering T, Schwartz JE, James GD. Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol. 22:1995;226-231.
11. Palatini P, Pessina AC, Graniero GR, et al. The relationship between overweight, life style and casual and 24-hour blood pressures in a population of male subjects with mild hypertension the results of the HARVEST study . G Ital Cardiol. 25:1995;977-989.
12. Cellina GU, Honour AJ, Littler WA. Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients. Am Heart J. 89:1975;18-25.
13. Kool MJF, Hoeks APG, Struijker Boudier HAJ, Reneman RS, Van Bortel LMAB. Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol. 22:1993;1881-1886.
14. Caro CG, Lever MJ, Parker KH, Fish PJ. Effect of cigarette smoking on the pattern of arterial blood flow possible insight into mechanisms underlying the development of arteriosclerosis . Lancet. 2:1987;11-13.
15. Pentecost B, Shillingford J. The acute effects of smoking on myocardial performance in patients with coronary arterial disease. Br Heart J. 26:1964;422-429.
16. Strauer BE, Mahmoud MA, Bayer F, Bohn I, Hahn B, Motz U. Global and regional wall motion and contractility of the left ventricle following cigarette smoking. Klin Wochenschr. 62:(Suppl II):1984;2-10.
17. Rietbrock N, Kunkel S, Wörner W, Eyer P. Oxygen-dissociation kinetics in the blood of smokers and nonsmokers interaction between oxygen and carbon monoxide at the hemoglobin molecule . Naunyn Schmiedebergs Arch Pharmakol. 345:1992;123-128.
18. Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med. 321:1989;1426-1432.
19. Aronow WS, Cassidy J, Vangrow JS, et al. Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation. 50:1974;340-347.
20. Calverley PMA, Leggett RJE, Flenley DC. Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema. BMJ. 283:1981;878-880.
21. Adams KF, Koch G, Chatterjee B, et al. Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol. 12:1988;900-999.
22. Sheps DS, Herbst MC, Hinderliter AL, et al. Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med. 113:1990;343-351.
23. DeBias DA, Banerjee CM, Birkhead NC, Greene CH, Scott SD, Harrer WV. Effects of carbon monoxide inhalation on ventricular fibrillation. Arch Environ Health. 31:1976;38-42.
24. Turino GM. Effect of carbon monoxide on the cardiorespiratory system. Carbon monoxide toxicity: physiology and biochemistry. Circulation. 63:1981;253A-259A.
25. Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol. 3:1984;879-886.
26. Nicod P, Rehr R, Winniford MD, Campbell WB, Firth BG, Hillis LD. Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol. 4:1984;964-971.
27. Raymond R, Lynch J, Underwood D, Leatherman A, Mehdi R. Myocardial infarction and normal coronary arteriography a 10-year clinical and risk analysis of 74 patients . J Am Coll Cardiol. 11:1988;471-477.
28. Caralis DG, Ubeydullah D, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation. 85:1992;905-909.
29. Winniford MD, Jansen DE, Reynolds GA, Apprill P, Black WH, Hillis LD. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. Am J Cardiol. 59:1987;203-207.
30. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez JAG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation constriction of epicardial and resistance vessels . J Am Coll Cardiol. 22:1993;642-647.
31. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 295:1976;573-577.
32. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function comparison of transdermal nicotine and cigarette smoking . J Am Coll Cardiol. 22:1993;1159-1167.
33. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease evidence for adrenergically mediated alterations in coronary artery tone . Circulation. 73:1986;662-667.
34. Peters RW, Benowitz NL, Valenti S, Modin G, Fisher ML. Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy. Am J Cardiol. 60:1987;1078-1082.
35. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation. 93:1996;2033-2036.
36. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations an analysis of published data . BMJ. 298:1989;784-788.
37. Freeman DJ, Griffin BA, Murray E, et al. Smoking and plasma lipoproteins in man effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution . Eur J Clin Invest. 23:1993;630-640.
38. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis. 79:1989;245-252.
39. Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. BMJ. 284:1982;1511-1513.
40. Pittilo RM, Woolf N. Cigarette smoking, endothelial cell injury and atherosclerosis. J Smoking-Related Dis. 4:1993;17-25.
41. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries observations on arteries from newborn children of smoking and nonsmoking mothers . Circ Res. 36:1975;579-589.
42. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
43. Nitenberg A, Antony I, Foult J-M. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med. 95:1993;71-77.
44. Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg. 80:1993;1242-1245.
45. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 90:1994;27-34.
46. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 226:1984;180-182.
47. Duthie GG, Arthur JR, Beattie JAG, et al. Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann N Y Acad Sci. 686:1993;120-129.
48. 2-isoprostanes) in smokers. N Engl J Med. 332:1995;1198-1203.
49. Heitzer T, Just H, Munzell T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:1996;6-9.
50. Petitti DB, Kipp H. The leukocyte count associations with intensity of smoking and persistence of effect after quitting . Am J Epidemiol. 123:1986;89-95.
51. Bain BJ, Rothwell M, Feher MD, Robinson R, Brown J, Sever PS. Acute changes in haematological parameters on cessation of smoking. J Roy Soc Med. 85:1992;80-82.
52. Grimm RH Jr., Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 254:1985;1932-1937.
53. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
54. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J. 115:1988;267-271.
55. Ernst E, Koenig W, Matrai A, Filipiak B, Stieber J. Blood rheology in healthy cigarette smokers. Arteriosclerosis. 8:1988;385-388.
56. Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease the pathogenesis of coronary artery disease and the acute coronary syndromes . N Engl J Med. 326:1992;242-250.
57. Ernst E. Fibrinogen its emerging role as a cardiovascular risk factor . Angiology. 45:1994;87-93.
58. Smith JR, Landaw SA. Smokers' polycythemia. N Engl J Med. 298:1978;6-10.
59. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 319:1988;1318-1330.
60. Okamura T, Noboru T. Mechanism underlying nicotine-induced relaxation in dog saphenous arteries. Eur J Pharmacol. 263:1994;85-91.
61. Benowitz NL. Pharmacology of nicotine addiction and therapeutics . Annu Rev Pharmacol Toxicol. 36:1996;597-613.
62. Benowitz NL, Porchet H, Sheiner L, Jacob P III. Nicotine absorption and cardiovascular effects with smokeless tobacco use comparison with cigarettes and nicotine gum . Clin Pharmacol Ther. 44:1988;23-28.
63. Benowitz NL, Jacob P III, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 221:1982;368-372.
64. Sutherland G, Russell MAH, Stapleton J, Feyerabend C, Ferno O. Nasal nicotine spray a rapid nicotine delivery system . Psychopharmacology. 108:1992;512-518.
65. Bayer F, Bohn I, Strauer BE. Das kontraktionsverhalten des linken ventrikels unter nikotinexposition. Therapiewoche. 35:1985;1968-1974.
66. Waeber B, Schaller M, Nussberger J, Bussien J, Hofbauer KG, Brunner HR. Skin blood flow reduction induced by cigarette smoking role of vasopressin . Am J Physiol. 249:1984;H895-H901.
67. Fewings JD, Rand MJ, Scroop GC, Whelan RF. The action of nicotine on the blood vessels of the hand and forearm in man. Br J Pharmacol. 26:1966;567-579.
68. Diana JN, Qian S, Heesch CM, Barron KW, Chien CY. Nicotine-induced skeletal muscle vasodilation is mediated by release of epinephrine from nerve terminals. Am J Physiol. 259:1990;H1718-H1729.
69. Woodman OL. Coronary vascular responses to nicotine in the anaesthetized dog. Naunyn Schmiedebergs Arch Pharmacol. 343:1991;65-69.
70. Kaijser L, Berglund B. Effect of nicotine on coronary blood-flow in man. Clin Physiol. 5:1985;541-552.
71. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of stunned myocardium in the canine model possible role of free radicals . Circulation. 89:1994;1272-1281.
72. Pfueller SL, Burns P, Mak K, Firkin BG. Effects of nicotine on platelet function. Haemostasis. 18:1988;163-169.
73. Becker BF, Terres W, Kratzer M, Gerlach E. Blood platelet function after chronic treatment of rats and guinea pigs with nicotine. Klin Wochenschr. 66:(Suppl XI):1988;28-36.
74. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries inhibition with phentolamine . Circulation. 65:1982;465-469.
75. Mundal HH, Hjemdahl P, Gjesdal K. Acute effects of low dose nicotine gum on platelet function in nonsmoking hypertensive and normotensive men. Eur J Clin Pharmacol. 47:1995;411-416.
76. 2 and prostacyclin metabolites in young men. Circulation. 83:1991;1698-1704.
77. Wennmalm A. Nicotine stimulates prostaglandin formation in the rabbit heart. Br J Pharmacol. 59:1977;95-100.
78. Wennmalm A, Alster P. Nicotine inhibits vascular prostacyclin but not platelet thromboxane formation. Gen Pharmacol. 14:1983;189-191.
79. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet. 1:1983;1248-1250.
80. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 76:1987;6-14.
81. Barrow SE, Ward PS, Sleightholm MA, Ritter JM, Dollery CT. Cigarette smoking profiles of thromboxane- and prostacyclin-derived products in human urine . Biochim Biophys Acta. 993:1989;121-127.
82. 2 and prostacyclin metabolites in women stratified by age. Circulation. 86:1992;1495-1500.
83. Stefanovich V, Gore I, Kajiyama G, Iwanaga Y. The effect of nicotine on dietary atherogenesis in rabbits. Exp Mol Pathol. 11:1969;71-81.
84. Strohschneider T, Oberhoff M, Hanke H, Hannekum A, Karsch KR. Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques. Clin Invest. 72:1994;908-912.
85. Fisher ER, Rothstein R, Wholey MH, Nelson R. Influence of nicotine on experimental atherosclerosis and its determinants. Arch Pathol. 96:1973;298-304.
86. Csonka E, Somogyi A, Augustin J, Haberbosch W, Schettler G, Jellinek H. The effect of nicotine on cultured cells of vascular origin. Virchows Arch [A]. 407:1985;441-447.
87. Thyberg J. Effects of nicotine on phenotypic modulation and initiation of DNA synthesis in cultured arterial smooth muscle cells. Virchows Arch B Cell Pathol. 52:1986;25-32.
88. Booyse FM, Osikowicz G, Quarfoot AJ. Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol. 102:1981;229-238.
89. Zimmerman M, McGeachie J. The effect of nicotine on aortic endothelium a quantitative ultrastructural study . Atherosclerosis. 63:1987;33-41.
90. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb. 12:1992;1305-1312.
91. Krupski WC, Olive GC, Weber CA, Rapp JH. Comparative effects of hypertension and nicotine on injury-induced myointimal thickening. Surgery. 102:1987;409-415.
92. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther. 37:1985;529-533.
93. Hellerstein MK, Benowitz NL, Neese RA, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest. 93:1994;265-272.
94. Cluette-Brown J, Mulligan J, Doyle K, Hagan S, Osmolski T, Hojnacki J. Oral nicotine induces an atherogenic lipoprotein profile. Proc Soc Exp Biol Med. 182:1986;409-413.
95. Quensel M, Agardh C-D, Nilsson-Ehle P. Nicotine does not affect plasma lipoprotein concentrations in healthy men. Scand J Clin Lab Invest. 49:1989;149-153.
96. Thomas GAO, Davies SV, Rhodes J, Russell MAH, Feyerabend C, Säwe U. Is transdermal nicotine associated with cardiovascular risk? J R Coll Physicians Lond. 29:1995;392-396.
97. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system. Prev Med. 23:1994;190-196.
98. Hwang SL, Waldholt M. Heart attacks reported in patch users still smoking. Wall Street Journal 1992 14 July.
99. U.S. Food and Drug Administration. Transcript of the 23rd meeting of the U.S. Food and Drug Administration. 1992.
100. 1. JAMA. 272:1994;1497-1505.
101. Murray RP, Bailey WC, Daniels K, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest. 109:1996;438-445.
102. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med. 154:1994;989-995.
103. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 335:1996;1792-1798.
104. Mahmarian JJ, Moye LA, Nasser GA, et al. A strategy of smoking cessation combined with nicotine patch therapy reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol. In press.
105. Marie PY, Danchin N, Durand JF, et al. Long-term prediction of major ischemic events by exercise thalium-201 single-photon emission computed tomography incremental prognostic value compared with clinical, exercise testing, catheterization, and radionuclide angiographic data . J Am Coll Cardiol. 26:1995;879-886.
106. Benowitz NL, Kuyt F, Jacob P III. Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther. 36:1984;74-81.
107. Benowitz NL, Jacob P III. Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther. 254:1990;1000-1005.
108. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MAH. Effect of transdermal nicotine patches on cigarette smoking a double blind crossover study . Psychopharmacology. 106:1992;421-427.
109. Rigotti NA, Eagle KA. Atrial fibrillation while chewing nicotine gum [letter]. JAMA. 255:1986;1018.
110. Stewart PM, Catterall JR. Chronic nicotine ingestion and atrial fibrillation. Br Heart J. 54:1985;222-223.
111. Ottervanger JP, Stricker BHC, Klomps HC. Transdermal nicotine clarifications, side effects, and funding [letter] . JAMA. 269:1993;1940.
112. Dacosta A, Guy JM, Tardy B, et al. Myocardial infarction and nicotine patch a contributing or causative factor? Eur Heart J. 14:1993;1709-1711.
113. Warner JG Jr., Little WC. Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med. 120:1994;695-696.
114. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA. 274:1995;1347-1352.
115. Pierce JR. Stroke following application of a nicotine patch [letter]. DICP. 28:1994;402.
116. Jackson M. Cerebral arterial narrowing with nicotine patch. Lancet. 342:1993;236-237.
117. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
118. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. JAMA. 271:1994;595-600.
119. Hurt RD, Dale LC, Offord KP, et al. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther. 54:1993;98-106.
120. Sachs DP, Benowitz NL, Bostrum AG, Hansen MD. Percent serum replacement and success of nicotine patch therapy. Am J Resp Crit Care Med 1995; A688.
121. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation a placebo-controlled clinical trial . Prev Med. 24:1995;41-47.
122. Schneider NG, Olmstead R, Mody FV, et al. Efficacy of a nicotine nasal spray in smoking cessation a placebo-controlled, double-blind trial . Addiction. 90:1995;1671-1682.
123. Porchet HC, Benowitz NL, Sheiner LB, Copeland JR. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest. 80:1987;1466-1471.